TRCT
LIN icon

Tower Research Capital (TRC)’s Linde LIN Stock Holding History

Tower Research Capital (TRC)’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Sell
29,993
-3,496
-10% -$1.65M 0.39% 35
2025
Q4 		$14.3M Buy
33,489
+16,370
+96% +$7.01M 0.35% 41
2025
Q3 		$8.13M Sell
17,119
-7,364
-30% -$3.49M 0.22% 76
2025
Q2 		$11.5M Buy
24,483
+9,165
+60% +$4.18M 0.31% 45
2025
Q1 		$7.13M Sell
15,318
-24,521
-62% -$11M 0.21% 66
2024
Q4 		$16.7M Buy
39,839
+22,214
+126% +$10.1M 0.33% 45
2024
Q3 		$8.4M Sell
17,625
-22,736
-56% -$10.4M 0.22% 58
2024
Q2 		$17.7M Buy
40,361
+2,666
+7% +$1.17M 0.3% 42
2024
Q1 		$17.5M Sell
37,695
-16,448
-30% -$7.12M 0.42% 35
2023
Q4 		$22.2M Buy
54,143
+26,661
+97% +$10.5M 0.27% 62
2023
Q3 		$10.2M Sell
27,482
-10,704
-28% -$4.07M 0.32% 48
2023
Q2 		$14.6M Buy
38,186
+30,697
+410% +$11.2M 0.48% 16
2023
Q1 		$2.66M Sell
7,489
-1,674
-18% -$561K 0.08% 153
2022
Q4 		$2.99M Sell
9,163
-25,892
-74% -$8.12M 0.12% 115
2022
Q3 		$9.45M Buy
35,055
+19,318
+123% +$5.55M 0.15% 120
2022
Q2 		$4.53M Sell
15,737
-60,216
-79% -$18.8M 0.1% 164
2022
Q1 		$24.3M Buy
75,953
+47,366
+166% +$14.6M 0.23% 80
2021
Q4 		$9.9M Buy
28,587
+11,362
+66% +$3.68M 0.17% 95
2021
Q3 		$5.05M Buy
17,225
+3,236
+23% +$984K 0.13% 97
2021
Q2 		$4.04M Sell
13,989
-22,933
-62% -$6.69M 0.11% 134
2021
Q1 		$10.3M Buy
36,922
+24,760
+204% +$6.42M 0.17% 98
2020
Q4 		$3.21M Sell
12,162
-1,124
-8% -$276K 0.1% 131
2020
Q3 		$3.16M Buy
13,286
+1,387
+12% +$336K 0.04% 177
2020
Q2 		$2.52M Buy
11,899
+11,799
+11,799% +$2.28M 0.1% 169
2020
Q1 		$17K Sell
100
-37
-27% -$7.3K ﹤0.01% 1797
2019
Q4 		$29K Sell
137
-9,613
-99% -$1.94M ﹤0.01% 1682
2019
Q3 		$1.89M Sell
9,750
-2,246
-19% -$435K 0.13% 131
2019
Q2 		$2.41M Sell
11,996
-502
-4% -$93.9K 0.16% 87
2019
Q1 		$2.2M Buy
12,498
+906
+8% +$151K 0.13% 112
2018
Q4 		$1.81M Buy
+11,592
New +$1.83M 0.13% 152

Other funds holding LIN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s LIN Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Linde (LIN) stake by 10% in Q1 2026, selling an estimated $1.65M and leaving 29,993 shares worth $14.9M. The position accounts for 0.39% of the portfolio, ranked #35.

Tower Research Capital (TRC) first reported a position in LIN in Q4 2018 and has held it in 30 quarters since. The position peaked at $24.3M in Q1 2022. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Tower Research Capital (TRC) held 29,993 shares of Linde worth $14.9M as of Q1 2026.
  • Tower Research Capital (TRC) sold 3,496 Linde shares in Q1 2026, an estimated $1.65M.
  • Linde made up 0.39% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #35 holding.
  • Tower Research Capital (TRC) first reported a position in Linde in Q4 2018 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s Linde position peaked at $24.3M in Q1 2022.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.